Concurrent RB1 Loss and <i>BRCA</i> Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous CarcinomaFlurina A.M. Saner, Jennifer M. Koziak, Timothy Budden et al.|Clinical Cancer Research|2024Cited by 14